Results 31 to 40 of about 936,356 (296)

Tropical Lung Disease

Chest, 1989
Lung disease is common in the tropics; lower respiratory tract infections are a major cause of mortality, especially in children under 5 years of age. The World Health Organization has launched strategies to tackle this killer of children. Infections, including tuberculosis and drug-resistant tuberculosis, find vulnerable hosts in the tropics where ...
Papanikolaou, Ilias C., Tsenempi, Xenia A.   +1 more
openaire   +4 more sources

Occupational lung disease [PDF]

Journal of the Royal College of Physicians of Edinburgh, 2013
Occupational medicine represents the interface between work and health. As such, its breadth encompasses issues of clinical medicine, epidemiology, occupational hygiene, toxicology, ethics, and the law. The diagnosis of an occupational lung disease has implications not only for the health of the worker, but also in some circumstances for the health of
P T Reid, P A Reid
openaire   +2 more sources

Non-Tuberculous Mycobacteria in Respiratory Specimens of Patients with Obstructive Lung Diseases—Colonization or Disease?

Antibiotics, 2020
Non-tuberculous mycobacteria (NTM) are increasingly a cause of human respiratory tract colonization and mycobacterial lung disease (NTM-LD), especially in patients with chronic lung diseases.
Monika Szturmowicz, Karina Oniszh, Dorota Wyrostkiewicz, Piotr Radwan-Rohrenschef, Dorota Filipczak, Anna Zabost   +5 more
doaj   +1 more source

A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR study

BMC Pulmonary Medicine, 2020
Background Pirfenidone is an antifibrotic agent approved for the treatment of idiopathic pulmonary fibrosis (IPF). The drug is available for Polish patients with IPF since 2017. The PolExPIR study aimed to describe the real-world data (RWD) on the Polish
Sebastian Majewski, Adam J. Białas, Małgorzata Buchczyk, Paweł Gomółka, Katarzyna Górska, Hanna Jagielska-Len, Agnieszka Jarzemska, Ewa Jassem, Dariusz Jastrzębski, Aleksander Kania, Marek Koprowski, Rafał Krenke, Jan Kuś, Katarzyna Lewandowska, Magdalena M. Martusewicz-Boros, Kazimierz Roszkowski-Śliż, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Karolina Szewczyk, Małgorzata Tomczak, Witold Tomkowski, Elżbieta Wiatr, Dariusz Ziora, Beata Żołnowska, Wojciech J. Piotrowski   +25 more
doaj   +1 more source

Large Pericardial Effusion—Diagnostic and Therapeutic Options, with a Special Attention to the Role of Prolonged Pericardial Fluid Drainage

Diagnostics, 2022
Background: Large pericardial effusion (LPE) is associated with high mortality. In patients with cardiac tamponade or with suspected bacterial etiology of pericardial effusion, urgent pericardial decompression is necessary.
Małgorzata Dybowska, Monika Szturmowicz, Katarzyna Błasińska, Juliusz Gątarek, Ewa Augustynowicz-Kopeć, Renata Langfort, Paweł Kuca, Witold Tomkowski   +7 more
doaj   +1 more source

Telocytes and lung disease.

Histology and histopathology, 2016
Telocytes (TCs) represent a new distinct type of interstitial cells found in many organs, including lungs. TCs are mainly defined by a small cellular body from which arise very long (hundreds of micrometers) extensions named telopodes. During the last years, TCs were characterized in respect with their microRNA profiles, gene features and proteome ...
Xiangdong Wang, Sanda Maria Cretoiu, Dragos Cretoiu, Dongli Song   +3 more
openaire   +4 more sources

Autoinflammatory disease in the lung [PDF]

Immunology, 2018
SummaryAscertaining the dominant cell type driving an immunological disease is essential to understanding the causal pathology and, therefore, selecting or developing an effective treatment. Classifying immunological diseases in this way has led to successful treatment regimens for many monogenic diseases; however, when the dominant cell type is ...
Scambler, T, Holbrook, J, Savic, S, McDermott, MF, Peckham, D   +4 more
openaire   +3 more sources

Comorbidities in unclassifiable interstitial lung disease

Respiratory Research, 2022
Background Comorbidities are common in interstitial lung diseases (ILD) and have an important association with survival, but the frequency and prognostic impact of comorbidities in unclassifiable interstitial lung disease (uILD) remains elusive. We aimed
Thomas Skovhus Prior, Charlotte Hyldgaard, Sebastiano Emanuele Torrisi, Sissel Kronborg-White, Claudia Ganter, Elisabeth Bendstrup, Michael Kreuter   +6 more
doaj   +1 more source

Mycobacterium szulgai Lung Disease or Breast Cancer Relapse—Case Report

Antibiotics, 2020
Cancers are one of the risk factors of non-tuberculous mycobacterial (NTM) lung disease. The majority of data in this group of patients concern infections caused by Mycobacterium avium—the most prevalent NTM species worldwide.
Anna Kempisty, Ewa Augustynowicz-Kopec, Lucyna Opoka, Monika Szturmowicz   +3 more
doaj   +1 more source

Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc

Arthritis Research & Therapy, 2022
Background Recently, a novel humanized mouse model for systemic sclerosis (SSc) was established by transferring peripheral blood mononuclear cells (PBMC) from patients with SSc to Rag2 −/− Il2rg −/− immunodeficient mice. Here, we aimed to investigate the
Yaqing Shu, Xiaoyang Yue, Jacqueline Wax, Brigitte Kasper, Junping Yin, Xiaoqing Wang, Liang Zhang, Marjan Ahmadi, Harald Heidecke, Antje Müller, Peter Lamprecht, Xinhua Yu, Gabriela Riemekasten, Frank Petersen   +13 more
doaj   +1 more source